Valeant sweetens takeover bid for Allergan

Canadian drug maker Valeant Pharmaceuticals International Inc. has added more cash to its offer to buy Allergan Inc., Reuters reports. The updated offer values U.S.-based Allergan, which makes Botox, at $49.44 billion. That translates to about $58.30 per Allergan share in cash, which is $10 more per share than the previous offer. Read more here.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Source Type: research